Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash & Current Investments (2019 - 2023)

Historic Cash & Current Investments for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $310.4 million.

  • ADC Therapeutics' Cash & Current Investments fell 1849.84% to $310.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $310.4 million, marking a year-over-year decrease of 1849.84%. This contributed to the annual value of $466544.0 for FY2022, which is 9989.84% down from last year.
  • Latest data reveals that ADC Therapeutics reported Cash & Current Investments of $310.4 million as of Q3 2023, which was down 1849.84% from $347.5 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Cash & Current Investments registered a high of $530.2 million during Q3 2021, and its lowest value of $115.55 during Q1 2020.
  • Over the past 5 years, ADC Therapeutics' median Cash & Current Investments value was $466544.0 (recorded in 2022), while the average stood at $145.5 million.
  • Per our database at Business Quant, ADC Therapeutics' Cash & Current Investments skyrocketed by 37998758.04% in 2021 and then plummeted by 3003.0% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Cash & Current Investments stood at $115.6 million in 2019, then tumbled by 99.57% to $494416.0 in 2020, then surged by 92771.65% to $459.2 million in 2021, then fell by 28.91% to $326.4 million in 2022, then fell by 4.91% to $310.4 million in 2023.
  • Its Cash & Current Investments stands at $310.4 million for Q3 2023, versus $347.5 million for Q2 2023 and $326441.0 for Q1 2023.